What we found on the web about Drug Candidate
Drug discovery - Wikipedia, the free encyclopedia
In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are discovered and/or designed. In the past most drugs have been discovered ...
Discovering Dengue Drugs – Together - Wikipedia, the free ...
Compounds predicted to bind strongly (protease inhibitors) are potential antiviral drug candidates. [1] This phase ended in August 2009. [4] Phase 2 "will use a more computationally ...
Syntrix Biosystems
Syntrix Biosystems is working to discover, develop and commercialize small molecule drug candidates to treat cancer, disorders of inflammation, and stimulate ...
NanoViricides, Inc. Anti-Herpes Drug Candidate Reduces Viral Load by ...
Aug 10, 2009 - NanoViricides, Inc. (OTC BB NNVC.OB) (the Company ), announced today that the herpes simplex viral load was reduced by 99.99 or 10,000 fold in in
Lexicon Pharmaceuticals, Inc. - Lexicon Pharmaceuticals Identifies New ...
• Currently No Marketed Drugs Targeting LX7101 Mechanism of Action • Glaucoma Affects 4 Million Americans, 65 Million Worldwide • Lexicon Now has Six Drug Candidates in Development
Drugs: Presidential Candidates' views
Tired of media reports of fundraising and poll results instead of policy issues? At Issues2000.org, you can see the view of every candidates on every issue.
Drugs: 2008 contenders' views
Tired of media reports of fundraising and poll results instead of policy issues? At OnTheIssues.org, you can see the view of every candidate on every issue.
Hemispherx Biopharma, Inc. -- Research and Development: Drug ...
Ampligen® Nucleic acid compounds represent a potential new class of pharmaceutical products that are designed to act at the molecular level for treatment of human diseases.
Syntrix Biosystems
Syntrix Biosystems is working to discover, develop and commercialize small molecule drug candidates to treat cancer, disorders of inflammation, and ...
NanoViricide's EKC Eye Drug Candidate Stopped Clinical Conjunctivitis ...
Jul 14, 2008 - NanoViricides, Inc. (OTC BB NNVC.OB) (the Company ) reported today that excellent efficacy of its EKC-Cide(TM) nanoviricide drug candidate was re
Lexicon's Drug Candidate LX1032 for Carcinoid Syndrome Receives Orphan ...
Lexicon's Drug Candidate LX1032 for Carcinoid Syndrome Receives Orphan Drug Designation From EMEA. - Phase 2 Clinical Trial in Patients with Carcinoid Syndrome Ongoing in U.S ...
Alligator Drug candidates
The FIND® technology enables Alligator to create new biological entities (NBEs) with the exact unique properties matching the need of safe and effective treatments. The technology ...
Entry added by Creative Administrator
Creative Administrator also edited:
Here is what users have to say about Drug Candidate

In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are discovered and/or designed.

Welcome to CWAnswers

CWAnswers is your guide to the sprawling world wide web. The directory aims to provide a useful guide made by users. You can share your knowledge as well - simply register and edit your first entry. For questions just contact the team at support - at - cwanswers.com.

Weblinks

Top 10

Things you find nowhere else.

Comments

You must be logged in to post a comment.

No comments yet on this topic. Be the first one!
These recent articles mention Drug Candidate
Synta's failed drug target may be reborn from biomarker discovery
Mass High Tech: The Journal of New England Technology
Eight months ago, Synta Pharmaceutical's promising Phase 2 drug trial for Elesclomol, a therapy targeting metastatic melanoma, had to be halted immediately. Now the drug target may be resurrected to treat a subset of patients.
Candidates take stances at forums
Glendale News-Press
LA CRESCENTA — Reducing local dependence on imported water, fighting teenage drug use and staying vigilant in the aftermath of the Station fire were top community concerns discussed Thursday at candidate forums for the Crescenta Valley Wate...
Angiochem’s ANG1005 Demonstrates Safety and Efficacy in Phase 1/2 ...
PR Inside
Angiochem, Inc. : a clinical-stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier to treat brain diseases, announced today that its lead drug candidate, ANG1005 : , has demonstrated a fa...
Flexion Therapeutics Raises $33 Million
Private Equity Hub
Brad Bolzon, Managing Director at Versant Ventures added: “The clinical team at Flexion has developed a unique capability to assess the potential of a given drug candidate as efficiently as possible. We look forward to applying ...
SC AG McMaster reaches $45M deal with drug maker
Spartanburg Herald-Journal
Published: Friday, October 23, 2009 at 3:04 p.m. Last Modified: Friday, October 23, 2009 at 3:04 p.m. COLUMBIA — South Carolina Attorney General Henry McMaster says the state has reached a $45 million settlement with drug maker Eli Lilly & ...
Acadia Cuts Work Force in Half
San Diego Business Journal
Shares of Acadia have lost more than two-thirds of their value since the company revealed disappointing results of its lead drug candidate, pimavanserin, in a late-stage trial. The drug is aimed at treating hallucinations and delusions asso...
FDA delays ruling on Acorda's MS drug until Jan.
AP via Yahoo! Finance
Acorda Therapeutics Inc. said Thursday the Food and Drug Administration delayed a ruling on its multiple sclerosis drug candidate Fampridine-SR by three months.
FDA issues emergency use authorization for intravenous antiviral drug peramivir in H1N1 patients
News-Medical-Net
The U.S. Food and Drug Administration announced today that, in response to a request from the U.S. Centers for Disease Control and Prevention, it has issued an emergency use authorization (EUA) for the investigational antiviral drug peramiv...